Lipopolysaccharide and lipoteichoic acid induce different innate immune responses in bovine mammary epithelial cells.
The objective of the present study was to characterize the innate immune responses induced by in vitro stimulation of bovine primary mammary epithelial cells (bMEC) using gram-negative lipopolysaccharide (LPS) and gram-positive lipoteichoic acid (LTA) bacterial cell wall components. Quantitative real-time PCR (qRT-PCR) was employed to examine the mRNA expression of a panel of 22 cytokines, chemokines, beta-defensins and components of the Toll-Like Receptor signaling pathway. Stimulation of bMEC with LPS for 24h elicited a marked increase in mRNA expression for IL-1beta, IL-8, TNFalpha, CXCL6 and beta-defensin while members of the Toll-Like Receptor pathway, although present, were largely unaffected. Surprisingly, stimulation of these cells with LTA for 24 h did not significantly alter the expression of these genes. A time course of the expression of IL-1beta, IL-8, TNFalpha, CXCL6 and beta-defensin was subsequently performed. The mRNA levels of all genes increased rapidly after stimulation for 2-4 h with both LPS and LTA but only the former treatment resulted in sustained responses. In contrast, the increased gene expression for LTA stimulated cells returned to resting levels after 8-16 h with the exception of beta-defensin, which remained up-regulated. The limited and unsustained cytokine response to LTA may explain why mastitis caused by gram-positive bacteria has greater potential for chronic intra-mammary infection than gram-negative infection. It was concluded that bovine mammary epithelial cells have a strong but differential capacity to mount innate immune responses to bacterial cell wall components.
Strandberg
Ylva
Y
CSIRO Livestock Industries, Queensland Bioscience Precinct, 306 Carmody Road, St Lucia 4067, QLD, Australia.
Gray
Christian
C
Vuocolo
Tony
T
Donaldson
Laurelea
L
Broadway
Mary
M
Tellam
Ross
R
D000818:Animals; D002417:Cattle; D002478:Cells, Cultured; D016207:Cytokines / Q000378:metabolism; D004847:Epithelial Cells / Q000187:drug effects* / Q000276:immunology*; D007113:Immunity, Innate / Q000187:drug effects*; D007633:Keratins / Q000378:metabolism; D007700:Kinetics; D008070:Lipopolysaccharides / Q000494:pharmacology*; D008321:Mammary Glands, Animal / Q000166:cytology / Q000187:drug effects* / Q000276:immunology*; D016328:NF-kappa B / Q000378:metabolism; D019887:Peanut Agglutinin / Q000494:pharmacology; D012333:RNA, Messenger / Q000235:genetics; D013682:Teichoic Acids / Q000494:pharmacology*; D023083:beta-Defensins / Q000378:metabolism
D016207:Cytokines; D008070:Lipopolysaccharides; D016328:NF-kappa B; D019887:Peanut Agglutinin; D012333:RNA, Messenger; D013682:Teichoic Acids; D023083:beta-Defensins; C009900:lipoteichoic acid; D007633:Keratins